Investigational Antiviral Therapy Models for the Prevention and Treatment of Congenital Cytomegalovirus Infection during Pregnancy
- 16 December 2020
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 65 (1)
Abstract
Congenital cytomegalovirus (HCMV) infection may cause significant fetal malformation, lifelong disease, and, in severe cases, fetal or neonatal death. Placental infection with HCMV is the major mechanism of mother-to-child transmission (MTCT) and fetal injury. Thus, any pharmaceutical antiviral interference to reduce viral load may reduce placental damage, MTCT, and fetal disease. However, there is currently no licensed HCMV antiviral for use during pregnancy. In this study, aciclovir and the HCMV-specific antivirals letermovir, maribavir, and cidofovir were compared with ganciclovir for antiviral effects in model systems of pregnancy, including first-trimester TEV-1 trophoblast cell cultures and third-trimesterex vivoplacental explant histocultures.Keywords
Funding Information
- Australian-Germany Joint Research Cooperation Scheme (RG162050/RG192195)
- Interdisciplinary Center for Clinical Research of the Faculty of Medicine of FAU (A88/MM-HS)
- Go8-DAAD (54390135)
- Wilhelm Sander-Stiftung (2018.121.1)
- Department of Health, Australian Government | National Health and Medical Research Council (APP1127717)
- Thrasher Research Fund (RG181876)
This publication has 39 references indexed in Scilit:
- Human Cytomegalovirus-Induces Cytokine Changes in the Placenta with Implications for Adverse Pregnancy OutcomesPLOS ONE, 2012
- In Vitro Evaluation of the Activities of the Novel Anticytomegalovirus Compound AIC246 (Letermovir) against Herpesviruses and Other Human Pathogenic VirusesAntimicrobial Agents and Chemotherapy, 2012
- The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral TerminaseJournal of Virology, 2011
- Oral Hexadecyloxypropyl-Cidofovir Therapy in Pregnant Guinea Pigs Improves Outcome in the Congenital Model of Cytomegalovirus InfectionAntimicrobial Agents and Chemotherapy, 2011
- Antibody Treatment Promotes Compensation for Human Cytomegalovirus-Induced Pathogenesis and a Hypoxia-Like Condition in Placentas with Congenital InfectionThe American Journal of Pathology, 2010
- Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replicationJournal of Clinical Investigation, 2010
- In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246Antimicrobial Agents and Chemotherapy, 2010
- Multidrug Resistance Conferred by Novel DNA Polymerase Mutations in Human Cytomegalovirus IsolatesAntimicrobial Agents and Chemotherapy, 2007
- Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole l -Riboside with a Unique Mode of ActionAntimicrobial Agents and Chemotherapy, 2002
- Activity of different antiviral drug combinations against human cytomegalovirus replication in vitroEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992